Mikio Mikami

No ORCID on file · 16 papers in corpus
article 2025
Clinica chimica acta; international journal of clinical chemistry ·doi:10.1016/j.cca.2025.120219

BACKGROUND AND AIMS: We identified a fully sialylated glycopeptide of the α-chain of Complement 4 binding protein (C4BP) in blood using Liquid chromatography/Mass spectrometry, which helps differentiate ovarian clear cell carcinoma (OCCC) f…

2024
Scientific reports ·doi:10.1038/s41598-024-70228-6

Epithelial ovarian cancer (EOC) is widely recognized as the most lethal gynecological malignancy; however, its early-stage detection remains a considerable clinical challenge. To address this, we have introduced a new method, named Comprehe…

review 2022
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15426

AIM: Histopathologic diagnosis of a subset of uterine smooth muscle tumors is challenging. We report a critical review regarding the clinicopathological point of view of 62 cases of subsequently recurred or metastasized leiomyoma. METHODS:…

article 2022
Analytical chemistry ·doi:10.1021/acs.analchem.1c04302

agglutinin (WFA)-reactive ceruloplasmin (CP) is a candidate marker for ovarian clear cell carcinoma (CCC) reported in our previous paper. Herein, a new measurement system was developed to investigate its potential as a serum marker for CCC.…

2021
International journal of molecular sciences ·doi:10.3390/ijms222011220

Ovarian cancers include several disease subtypes and patients often present with advanced metastatic disease and a poor prognosis. New biomarkers for early diagnosis and targeted therapy are, therefore, urgently required. This study uses an…

2019
Journal of gynecologic oncology ·doi:10.3802/jgo.2019.30.e39

The Asian Society of Gynecologic Oncology International Workshop 2018 on gynecologic oncology was held in the Ajou University Hospital, Suwon, Korea on the 24th to 25th August 2018. The workshop was an opportunity for Asian doctors to discu…

book 2019
·doi:10.1007/978-981-13-1519-0
2019
Gynecologic Oncology ·doi:10.1016/j.ygyno.2019.03.243

ObjectiveTo examine the trends of epithelial ovarian cancer histologic subtypes in Japan.MethodsA nationwide retrospective registry study was performed between 2002 and 2015 (Japan cohort, n = 48,640). Trends were also examined in The Surve…

article 2017
article 2016
·doi:10.1016/j.ygyno.2016.04.092
article 2016
2016
Oncology letters ·doi:10.3892/ol.2016.5082

Thymidine phosphorylase (TP) is structurally similar to platelet-derived endothelial cell growth factor, and it activates 5-fluorouracil (5-FU) prodrugs and also promotes angiogenesis. In the present study, the possibility of using TP expre…

article 2015
Gynecologic oncology ·doi:10.1016/j.ygyno.2015.10.012

OBJECTIVE: While a certain fraction of endometriomas can develop de novo epithelial ovarian cancer (EOC) such as clear cell carcinoma (OCCC), there is currently no useful biomarker available for early detection of OCCC from endometriomas. T…

article 2010
·doi:10.5180/jsgoe.26.585

Objective: To report a case of TOA from bilateral ovarian endometriomas and discuss how fertility may be preserved.Case: A 37-year-old gravida 1/para 0 female underwent treatment for infertility for seven years. Her initial laparoscopy, at …

article 2009
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists ·doi:10.1097/pgp.0b013e31818e101f

A 73-year-old postmenopausal Japanese woman presented with a complaint of slight fever and weight loss. An elevated level of CA125 in the blood favored a diagnosis of malignant uterine body tumor, but was not confirmed by endometrial cytolo…

article 2003
Journal of assisted reproduction and genetics ·doi:10.1023/a:1021254620888

PurposeTo determine whether there is any association between the expression of endometrial integrin alphavbeta3 and repeated IVF-ET failure and to examine the effect of danazol treatment on alphavbeta3 expression.MethodsThis prospective stu…